Author
The author works as a Correspondent with BW Businessworld
124 countries signed the health and climate change declaration at COP28 but how big of a dent will this make in the global carbon emissions?
Read More
The total deal value in healthcare and pharma combined is pegged somewhere over $6 billion in private equity investments alone with a deal value of $3.4 billion in M&A activities in the first eight to nine months of 2023
Read More
From April to October, India’s drug exports grew by 8 per cent year on year to USD 15.7 billion versus USD 14.5 billion in the same period last year. “In October, the exports jumped by 29 per cent against 5 per cent growth all along this year and due to this momentum, we are projecting that pharmaceutical exports can clock 28 billion USD in FY24,” the Chairman said
Read More
India is ranked as the third largest pharmaceutical market in terms of volumes and 14th by value simply translating that the country produces more copycat drugs than the innovator medications
Read More
Indegene is bracing up for its maiden listing at the Indian exchanges, the company has an intriguing story to tell of its inception with growing financials in the present day and high hopes for its future growth
Read More
In an exclusive interaction with BW Healthcare World, Gaurav Agarwal, Co-founder and Chief Technology Officer, Tata 1mg speaks on the regulatory challenges, the firm's profitability, diversifying the revenue models and plans for future growth
Read More
Sun Pharma reported a profit after tax of Rs 2,375 crore in the September quarter up by 5 per cent against Rs 2,262 crore in the corresponding quarter last year
Read More
Mankind Pharma's domestic revenue grew by 7 per cent YoY to Rs 2,529 crores while exports rose by 159 per cent YoY to Rs 179 crores
Read More
The company is raising around Rs 1000 crore from three leading banks including JP Morgan, CITI and SMBC for financing Rs 1600 crore acquisition and the remaining Rs 600 crore from internal accruals
Read More
Speaking to BW Healthcare World in the post-results briefing Umang Vohra, MD and Global CEO, of Cipla said that the company is looking at a mixed plan of greenfield and brownfield projects for expanding in the US and the Indian market
Read More
